Advertisement
Screener

INTEGRATED BIOPHARMA INC (INBP) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

2.0 / 5 stars · 47/116 Roast Me

INTEGRATED BIOPHARMA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

INTEGRATED BIOPHARMA INC (INBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 51.67 thousand shares for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-05-08

  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was -1.00 shares, a 100.01% decline year-over-year.
  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 11.17K shares.
  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 11.83K shares, a 34.26% decline from fiscal 2024.
  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 18.00K shares.
  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 44.70K shares, a 1241.13% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed
2026-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08
51.67K shares
10-Q · filed 2026-05-08
2025-12-3151.67K shares
10-Q · filed 2026-02-11
2025-06-30-1.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
11.17K shares
derived: sum of 2 quarters · filed 2025-09-23
11.17K shares
derived: sum of 3 quarters · filed 2025-09-23
11.83K shares
10-K · filed 2025-09-23
2025-03-3111.17K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14
11.17K shares
derived: sum of 2 quarters · filed 2025-05-14
11.83K shares
10-Q · filed 2025-05-14
20.67K shares
derived: sum of 4 quarters · filed 2025-09-23
2024-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13
667.00 shares
10-Q · filed 2025-02-13
9.50K shares
derived: sum of 3 quarters · filed 2025-09-23
6.73K shares
derived: sum of 4 quarters · filed 2025-09-23
2024-09-30667.00 shares
10-Q · filed 2024-11-13
9.50K shares
derived: sum of 2 quarters · filed 2025-09-23
6.73K shares
derived: sum of 3 quarters · filed 2025-09-23
18.67K shares
derived: sum of 4 quarters · filed 2025-09-23
2024-06-308.83K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
6.07K shares
derived: sum of 2 quarters · filed 2025-09-23
18.00K shares
derived: sum of 3 quarters · filed 2025-09-23
18.00K shares
10-K · filed 2025-09-23
2024-03-31-2.77K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-10
9.17K shares
derived: sum of 2 quarters · filed 2024-05-10
9.17K shares
10-Q · filed 2024-05-10
-582.78K shares
derived: sum of 4 quarters · filed 2024-09-20
2023-12-3111.93K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-12
11.93K shares
10-Q · filed 2024-02-12
-580.01K shares
derived: sum of 3 quarters · filed 2024-09-20
-361.72K shares
derived: sum of 4 quarters · filed 2024-09-20
2023-09-300.00 shares
10-Q · filed 2023-11-09
-591.95K shares
derived: sum of 2 quarters · filed 2024-09-20
-373.65K shares
derived: sum of 3 quarters · filed 2024-09-20
2023-06-30-591.95K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20
-373.65K shares
derived: sum of 2 quarters · filed 2024-09-20
0.00 shares
10-K · filed 2024-09-20
2023-03-31218.30K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11
591.95K shares
10-Q · filed 2023-05-11
2022-12-31373.65K shares
10-Q · filed 2023-02-10
2022-06-3014.07K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-15
29.67K shares
derived: sum of 2 quarters · filed 2023-09-15
44.70K shares
10-K · filed 2023-09-15
2022-03-3115.60K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12
30.63K shares
10-Q · filed 2022-05-12
2021-12-3115.03K shares
10-Q · filed 2022-02-10
2021-06-303.33K shares
10-K · filed 2022-09-13
2020-06-30137.50K shares
10-K · filed 2021-09-02
2019-06-3017.50K shares
10-K · filed 2020-09-23
2018-06-30118.33K shares
10-K · filed 2019-08-29
2017-06-30271.67K shares
10-K · filed 2018-09-12
2016-06-3080.00K shares
10-K · filed 2017-09-01
2015-06-3018.00K shares
10-K · filed 2016-09-02
2014-06-3073.00K shares
10-K · filed 2015-09-04
2013-06-3024.00K shares
10-K · filed 2014-09-08
-24.00K shares
10-K · filed 2013-09-30
2012-06-30-61.50K shares
10-K · filed 2013-09-30
2011-06-30-223.00K shares
10-K · filed 2012-10-15